Concurrent chemoradiation for locally advanced oropharyngeal cancer

Nam P. Nguyen, Paul Vos, Herbert J. Smith, Phuc D. Nguyen, Alan Alfieri, Ulf Karlsson, Suresh Dutta, Claire Lemanski, Ly M. Nguyen, Sabah Sallah

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Purpose: The aim of this study was to assess the survival, pattern of failure, morbidity, and prognostic factors of concurrent chemoradiation for locally advanced oropharyngeal cancer. Materials and methods: A retrospective survey of patients who underwent chemotherapy and radiation for locally advanced oropharyngeal carcinoma at the Veteran Affairs North Texas Health Care System, Dallas, Tex. Results: Between December 1999 and September 2004, 48 patients with locally advanced oropharyngeal cancer underwent concurrent chemotherapy and radiation. At a median follow-up of 23 months, the 3- and 5-year survival for the whole group were, respectively, 52% and 41%. Seventeen patients (35%) developed recurrences. There were 12 (25%) locoregional failures (6 local failures alone and 6 local and regional failures). Distant metastases developed in 8 patients (5 alone, 3 associated with locoregional failures). Four patients (8%) developed second primaries. No difference was observed in survival between base of tongue and tonsillar carcinoma (P = .32). The 5-year survival for T1-T2 and T3-T4 tumors was, respectively, 84% and 27% (P = .01). No patient with T1-T2 tumors developed distant metastases (P = .04). Forty-five patients (94%) developed toxicity grade 3 to 4 (40 mucositis and 26 hematological). The median weight loss was 18 lb (range, 0-47 lb). Eight patients (16%) developed aspiration pneumonia during and after treatment. Five patients (10%) died of aspiration (2 during and 3 post treatment). Four patients (8%) developed esophageal strictures requiring repeated dilatations post treatment. Two patients had radionecrosis (1 soft tissue and 1 bone) requiring hyperbaric oxygen. Eighteen patients (37%) had prolonged tube feedings (>3 months) after treatments because of severe dysphagia or aspiration. Conclusion: Concurrent chemoradiation provided good locoregional control for locally advanced oropharyngeal carcinoma. Patients with small tumors (T1-T2) had excellent survival. The poor prognosis associated with large tumors may be due to the risk of developing distant metastases. Acute and late toxicities remained significant. Aspiration pneumonia and severe dysphagia were the most prevalent complications of the combined modality approach.

Original languageEnglish (US)
Pages (from-to)3-8
Number of pages6
JournalAmerican Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume28
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Oropharyngeal Neoplasms
Survival
Aspiration Pneumonia
Deglutition Disorders
Neoplasm Metastasis
Carcinoma
Neoplasms
Radiation
Drug Therapy
Esophageal Stenosis
Mucositis
Enteral Nutrition
Veterans
Therapeutics
Tongue

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Concurrent chemoradiation for locally advanced oropharyngeal cancer. / Nguyen, Nam P.; Vos, Paul; Smith, Herbert J.; Nguyen, Phuc D.; Alfieri, Alan; Karlsson, Ulf; Dutta, Suresh; Lemanski, Claire; Nguyen, Ly M.; Sallah, Sabah.

In: American Journal of Otolaryngology - Head and Neck Medicine and Surgery, Vol. 28, No. 1, 01.2007, p. 3-8.

Research output: Contribution to journalArticle

Nguyen, NP, Vos, P, Smith, HJ, Nguyen, PD, Alfieri, A, Karlsson, U, Dutta, S, Lemanski, C, Nguyen, LM & Sallah, S 2007, 'Concurrent chemoradiation for locally advanced oropharyngeal cancer', American Journal of Otolaryngology - Head and Neck Medicine and Surgery, vol. 28, no. 1, pp. 3-8. https://doi.org/10.1016/j.amjoto.2006.03.007
Nguyen, Nam P. ; Vos, Paul ; Smith, Herbert J. ; Nguyen, Phuc D. ; Alfieri, Alan ; Karlsson, Ulf ; Dutta, Suresh ; Lemanski, Claire ; Nguyen, Ly M. ; Sallah, Sabah. / Concurrent chemoradiation for locally advanced oropharyngeal cancer. In: American Journal of Otolaryngology - Head and Neck Medicine and Surgery. 2007 ; Vol. 28, No. 1. pp. 3-8.
@article{90c7795b537f4b4282f87c3477668ce4,
title = "Concurrent chemoradiation for locally advanced oropharyngeal cancer",
abstract = "Purpose: The aim of this study was to assess the survival, pattern of failure, morbidity, and prognostic factors of concurrent chemoradiation for locally advanced oropharyngeal cancer. Materials and methods: A retrospective survey of patients who underwent chemotherapy and radiation for locally advanced oropharyngeal carcinoma at the Veteran Affairs North Texas Health Care System, Dallas, Tex. Results: Between December 1999 and September 2004, 48 patients with locally advanced oropharyngeal cancer underwent concurrent chemotherapy and radiation. At a median follow-up of 23 months, the 3- and 5-year survival for the whole group were, respectively, 52{\%} and 41{\%}. Seventeen patients (35{\%}) developed recurrences. There were 12 (25{\%}) locoregional failures (6 local failures alone and 6 local and regional failures). Distant metastases developed in 8 patients (5 alone, 3 associated with locoregional failures). Four patients (8{\%}) developed second primaries. No difference was observed in survival between base of tongue and tonsillar carcinoma (P = .32). The 5-year survival for T1-T2 and T3-T4 tumors was, respectively, 84{\%} and 27{\%} (P = .01). No patient with T1-T2 tumors developed distant metastases (P = .04). Forty-five patients (94{\%}) developed toxicity grade 3 to 4 (40 mucositis and 26 hematological). The median weight loss was 18 lb (range, 0-47 lb). Eight patients (16{\%}) developed aspiration pneumonia during and after treatment. Five patients (10{\%}) died of aspiration (2 during and 3 post treatment). Four patients (8{\%}) developed esophageal strictures requiring repeated dilatations post treatment. Two patients had radionecrosis (1 soft tissue and 1 bone) requiring hyperbaric oxygen. Eighteen patients (37{\%}) had prolonged tube feedings (>3 months) after treatments because of severe dysphagia or aspiration. Conclusion: Concurrent chemoradiation provided good locoregional control for locally advanced oropharyngeal carcinoma. Patients with small tumors (T1-T2) had excellent survival. The poor prognosis associated with large tumors may be due to the risk of developing distant metastases. Acute and late toxicities remained significant. Aspiration pneumonia and severe dysphagia were the most prevalent complications of the combined modality approach.",
author = "Nguyen, {Nam P.} and Paul Vos and Smith, {Herbert J.} and Nguyen, {Phuc D.} and Alan Alfieri and Ulf Karlsson and Suresh Dutta and Claire Lemanski and Nguyen, {Ly M.} and Sabah Sallah",
year = "2007",
month = "1",
doi = "10.1016/j.amjoto.2006.03.007",
language = "English (US)",
volume = "28",
pages = "3--8",
journal = "American Journal of Otolaryngology - Head and Neck Medicine and Surgery",
issn = "0196-0709",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Concurrent chemoradiation for locally advanced oropharyngeal cancer

AU - Nguyen, Nam P.

AU - Vos, Paul

AU - Smith, Herbert J.

AU - Nguyen, Phuc D.

AU - Alfieri, Alan

AU - Karlsson, Ulf

AU - Dutta, Suresh

AU - Lemanski, Claire

AU - Nguyen, Ly M.

AU - Sallah, Sabah

PY - 2007/1

Y1 - 2007/1

N2 - Purpose: The aim of this study was to assess the survival, pattern of failure, morbidity, and prognostic factors of concurrent chemoradiation for locally advanced oropharyngeal cancer. Materials and methods: A retrospective survey of patients who underwent chemotherapy and radiation for locally advanced oropharyngeal carcinoma at the Veteran Affairs North Texas Health Care System, Dallas, Tex. Results: Between December 1999 and September 2004, 48 patients with locally advanced oropharyngeal cancer underwent concurrent chemotherapy and radiation. At a median follow-up of 23 months, the 3- and 5-year survival for the whole group were, respectively, 52% and 41%. Seventeen patients (35%) developed recurrences. There were 12 (25%) locoregional failures (6 local failures alone and 6 local and regional failures). Distant metastases developed in 8 patients (5 alone, 3 associated with locoregional failures). Four patients (8%) developed second primaries. No difference was observed in survival between base of tongue and tonsillar carcinoma (P = .32). The 5-year survival for T1-T2 and T3-T4 tumors was, respectively, 84% and 27% (P = .01). No patient with T1-T2 tumors developed distant metastases (P = .04). Forty-five patients (94%) developed toxicity grade 3 to 4 (40 mucositis and 26 hematological). The median weight loss was 18 lb (range, 0-47 lb). Eight patients (16%) developed aspiration pneumonia during and after treatment. Five patients (10%) died of aspiration (2 during and 3 post treatment). Four patients (8%) developed esophageal strictures requiring repeated dilatations post treatment. Two patients had radionecrosis (1 soft tissue and 1 bone) requiring hyperbaric oxygen. Eighteen patients (37%) had prolonged tube feedings (>3 months) after treatments because of severe dysphagia or aspiration. Conclusion: Concurrent chemoradiation provided good locoregional control for locally advanced oropharyngeal carcinoma. Patients with small tumors (T1-T2) had excellent survival. The poor prognosis associated with large tumors may be due to the risk of developing distant metastases. Acute and late toxicities remained significant. Aspiration pneumonia and severe dysphagia were the most prevalent complications of the combined modality approach.

AB - Purpose: The aim of this study was to assess the survival, pattern of failure, morbidity, and prognostic factors of concurrent chemoradiation for locally advanced oropharyngeal cancer. Materials and methods: A retrospective survey of patients who underwent chemotherapy and radiation for locally advanced oropharyngeal carcinoma at the Veteran Affairs North Texas Health Care System, Dallas, Tex. Results: Between December 1999 and September 2004, 48 patients with locally advanced oropharyngeal cancer underwent concurrent chemotherapy and radiation. At a median follow-up of 23 months, the 3- and 5-year survival for the whole group were, respectively, 52% and 41%. Seventeen patients (35%) developed recurrences. There were 12 (25%) locoregional failures (6 local failures alone and 6 local and regional failures). Distant metastases developed in 8 patients (5 alone, 3 associated with locoregional failures). Four patients (8%) developed second primaries. No difference was observed in survival between base of tongue and tonsillar carcinoma (P = .32). The 5-year survival for T1-T2 and T3-T4 tumors was, respectively, 84% and 27% (P = .01). No patient with T1-T2 tumors developed distant metastases (P = .04). Forty-five patients (94%) developed toxicity grade 3 to 4 (40 mucositis and 26 hematological). The median weight loss was 18 lb (range, 0-47 lb). Eight patients (16%) developed aspiration pneumonia during and after treatment. Five patients (10%) died of aspiration (2 during and 3 post treatment). Four patients (8%) developed esophageal strictures requiring repeated dilatations post treatment. Two patients had radionecrosis (1 soft tissue and 1 bone) requiring hyperbaric oxygen. Eighteen patients (37%) had prolonged tube feedings (>3 months) after treatments because of severe dysphagia or aspiration. Conclusion: Concurrent chemoradiation provided good locoregional control for locally advanced oropharyngeal carcinoma. Patients with small tumors (T1-T2) had excellent survival. The poor prognosis associated with large tumors may be due to the risk of developing distant metastases. Acute and late toxicities remained significant. Aspiration pneumonia and severe dysphagia were the most prevalent complications of the combined modality approach.

UR - http://www.scopus.com/inward/record.url?scp=33845285851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845285851&partnerID=8YFLogxK

U2 - 10.1016/j.amjoto.2006.03.007

DO - 10.1016/j.amjoto.2006.03.007

M3 - Article

VL - 28

SP - 3

EP - 8

JO - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

JF - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

SN - 0196-0709

IS - 1

ER -